Nelson Sonja

CFO at Ambrx Biopharma, Inc.; Chief Financial Officer at IBRX

Sold, on record
$906k
Dollars the filings state
Form 4 sales
3
Latest Oct 27, 2023
Form 144 notices
1
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale IBRXUnusual
    Jan 4, 2021 2021

    Sold 39,271 shares at $13.62 ($535k)

    Nelson Sonja, Chief Financial Officer

    Sold 65.8% of holdings ($813k position)20,410 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale IBRXUnusual
    Jan 12, 2021 +8 days

    Sold 16,364 shares at $15.00 ($245k)

    Nelson Sonja, Chief Financial Officer

    Sold 51.5% of holdings ($477k position)15,410 shares leftFiling

  3. 3 Form 144 notice Ambrx Biopharma, Inc.Notice
    Oct 27, 2023 +1018 days

    Filed to sell 12,778 shares ($125k)

    Nelson Sonja, CFO

    No 10b5-1 planFirst sale on recordFiling

  4. 4 Form 4 sale Ambrx Biopharma, Inc.Routine
    Oct 27, 2023 same day

    Sold 12,778 shares at $9.82 ($125k)

    Nelson Sonja, Chief Financial Officer

    10b5-1 planSold 8.9% of holdings ($1.4M position)130,079 shares leftFirst sale on recordFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Nelson Sonja
Source
Oct 27, 2023Oct 31, 2023Ambrx Biopharma, Inc.Chief Financial OfficerForm 4 sale12,778$125k8.9%RoutineSEC
Oct 27, 2023Oct 27, 2023Ambrx Biopharma, Inc.CFOForm 144 notice12,778$125kNoticeSEC
Jan 12, 2021Jan 13, 2021IBRXChief Financial OfficerForm 4 sale16,364$245k51.5%UnusualSEC
Jan 4, 2021Jan 6, 2021IBRXChief Financial OfficerForm 4 sale39,271$535k65.8%UnusualSEC